Article R1125-11 of the French Public Health Code
The Director General of the Agence nationale de sécurité du médicament et des produits de santé may notify the sponsor of any objections to the implementation of the research in a reasoned letter. He will inform the relevant personal data protection committee. It sets a deadline for the sponsor to submit its amended project. The sponsor may amend the content of his research project and send it to the Director…